Role of TJP1 in Sensitivity and Resistance to Proteasome Inhibitors in Myeloma

Richard A Flavell

Understanding Hemotopoietic Neoplasias using Humanized Mice

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Jens G Lohr

Determining the mutational landscape of circulating multiple myeloma cells

Multiple myeloma and immunoproliferative diseases

Pathology

Timothy A Springer

Integrin-Targeted siRNA Delivery for Therapeutic Gene Silencing in Blood Cancers

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Kelvin P. Lee

CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival

Multiple myeloma and immunoproliferative diseases

Elad Ziv

Influence of germ line genetic variation on myeloma progression and survival

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

William Figg

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

Jetze J Tepe

Characterization of Non-Competitive Proteasome Binding

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Tracy L Mcgaha

The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Jing Yang

Targeting adipocyte-secreted chemerin for chemotherapy resistance in myeloma

Multiple myeloma and immunoproliferative diseases